AIM

Aim Immunotech

• TipRanks·18h ago

  AIM ImmunoTech Induces Warrant Exercises to Raise Capital

• TipRanks·04/16 13:59

  AIM ImmunoTech highlights accelerating momentum in pancreatic cancer program

• TipRanks·04/10 21:14

  AIM ImmunoTech Expands At-The-Market Equity Offering Capacity

• Dow Jones·04/10 09:50

  AIM ImmunoTech Is Maintained at Buy by Ascendiant Capital

• Dow Jones·04/10 09:50

  AIM ImmunoTech Price Target Cut to $10.00/Share From $22.00 by Ascendiant Capital

• TipRanks·03/20 14:55

  Biotech Alert: Searches spiking for these stocks today

• TipRanks·03/19 14:11

  3 Penny Stocks to Watch Now, 3/19/26

• TipRanks·03/18 17:23

  Morning News Wrap-Up 3/18/26: Today’s Biggest Stock Market Stories!

• NASDAQ·03/18 16:26

  AIM ImmunoTech Stock Gains Over Final Approval Of Novel Cancer Therapy Patent In Japan

• TipRanks·03/18 13:47

  Why Is AIM ImmunoTech Stock (AIM) Up Today?

• TipRanks·03/18 12:51

  AIM announces approval of patent for Ampligen in Japan

• TipRanks·03/06 22:53

  AIM ImmunoTech Completes Series G Preferred Rights Offering

• TipRanks·03/04 15:25

  Biotech Alert: Searches spiking for these stocks today

• TipRanks·03/04 14:05

  AIM ImmunoTech announces preliminary results of rights offering

• Dow Jones·03/04 14:00

  Press Release: AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million